Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.

2022 Startups to Watch
stats here
Related Posts on Startland News
Lean Lab eyes $25K in national pitch contest
The Lean Lab, a Kansas City-based education innovation incubator, is hoping to strike gold in a national pitch competition in California. The organization on Wednesday will be pitching its model in the Teach For America Social Innovation Awards, an annual competition in which the Lean Lab hopes to snag a $25,000 prize. Lean Lab is the…
Major network provider taps SquareOffs for ‘Rant Offs’
SquareOffs recently landed a client that may place its web-based debate technology in front of millions of more people. The company partnered with digital media network Rant Inc. to offer its online debate and polling tech to engage Rant’s readers and increase their advertising revenue. “It’s one of the bigger contracts that we’re apart of,”…
Week of events creates startups, builds entrepreneurial community
The Kansas City entrepreneurial community is prepping for a week-long celebration of startups and entrepreneurship. 1WeekKC, which kicks off on May 29 and continues throughout the entire first week of June, will include a series of events created to empower entrepreneurs to come together, share ideas, get inspired, celebrate and connect. A group of community…

